Antibodies are like "guided missiles" that find and attack cancer cells, but cancer-causing mutations inside cells have remained a "blind spot" for treatment because antibodies cannot reach them. KAIST researchers have now succeeded in precisely targeting intracellular cancer mutations using a newly designed antibody created through computational methods.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Researchers uncover 'hidden key' to immunotherapy for intractable brain tumors | 2 | 8 | 20-07-2026 |
| 2 | Autoantibodies could shape cancer risk, growth and response to immunotherapy | 0 | 9.66 | 25-07-2026 |
| 3 | Redesigned lung cancer drug matches tumor control with fewer off-target interactions | 0 | 9.72 | 24-07-2026 |
| 4 | Anticancer 'nanoswitch' technology shows promise in animal model of triple-negative breast cancer, colorectal cancer | 5 | 7 | 10-07-2026 |
| 5 | Researchers discover novel SRV2 envelope protein for efficient CAR immune cell production | 5 | 7 | 01-07-2026 |
| 6 | روبوتات ترصد الخلايا السرطانية "الصامدة" بعد العلاج | 0 | 7 | 16-06-2026 |
| 7 | New blood test for noncoding RNA significantly improves cancer detection | 7 | 8 | 31-08-2023 |
| 8 | Proalt desarrolla anticuerpos de precisión para transformar el tratamiento del cáncer metastásico | 5 | 7 | 22-06-2026 |
| 9 | Ученые создали оружие против неизлечимого рака | 7 | 8 | 15-07-2026 |